MINNEAPOLIS — Former GlaxoSmithKline plc chief executive officer Sir Andrew Witty has been named CEO of Optum, the health services, technology and pharmacy benefits management unit of health insurance giant UnitedHealth Group. Plans call for Witty to start as Optum CEO on July 1. He takes over from Larry Renfro, vice chair of UnitedHealth Group, who has
LONDON — Brian McNamara has been promoted to chief executive officer of GlaxoSmithKline plc’s consumer health business. GSK said McNamara assumes the GSK Consumer Healthcare CEO post and joins GSK’s corporate executive team effective immediately. He takes the reins from Emma Walmsley, who just over a week ago was named to succeed Sir Andrew Witty
LONDON — Emma Walmsley has been named to succeed Sir Andrew Witty as chief executive officer of GlaxoSmithKline plc. The drug maker said Tuesday that Walmsley, CEO of GSK Consumer Healthcare, is slated to take the reins from Witty when he retires on March 31, 2017. Plans call for her to become a member of
LONDON — Sir Andrew Witty, chief executive officer of GlaxoSmithKline plc, plans to retire from the company next year. GSK announced Witty’s retirement Thursday in releasing its 2015 annual report to shareholders. Plans call for Witty to step down from the CEO post on March 31, 2017. The board of directors plans to conduct a
